Orion Corporation is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others.
In 2024 Orion's net sales amounted to EUR 1,542 million and the company employed about 3,700 professionals worldwide, dedicated to building well-being. Orion's A and B shares are listed on Nasdaq Helsinki.
Product related questions and feedback: https://www.orionpharma.com/feedback
Company Details
- Employees
- 3.05K
- Address
- Orionintie 1a, Espoo,fi-02101,finland
- Phone
- +46 8 623 64 40
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- orionpharma.co.uk
- HQ
- Espoo
Orion Pharma Questions
Orion Pharma's helpline number is +46 8 623 64 40
Orion Pharma's website is orionpharma.co.uk
Orion Pharma's LinkedIn profile is https://fi.linkedin.com/company/orion-pharma
Orion Pharma has
3.05K employees.
View email and phone details for 3.05K
employees at Orion Pharma.
Orion Pharma's industry is
Pharmaceutical Manufacturing
Orion Pharma's top competitors are
Oriola Corporation,
Nanoform,
Orchard Therapeutics - U.s.,
Gsk,
Bayer,
Pfizer,
Astrazeneca,
Novo Nordisk,
Orion Pharma Ltd,
Fermion Oy.
Orion Pharma's support email address is infoswe@orionpharma.com
Orion Pharma's categories are Pharmaceutical Manufacturing
